Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by MorganEarpon Jul 16, 2018 8:57pm

43 Views

Post# 28324473

The vile CANCER Goldenpuke still SELF RATING FIVE STARS

0 minutes ago 11 Reads
Post# 28324451

Does he not realize how shallow and pathetic he looks while CONSTANTLY DOING THIS SELF RATIING. I am beginning to think he is some kinda reatard....cause only a "tard would continue to do this time after time after time, while being EXPOSED time after time after time. How pathetic is that folks, you self rate your posts before the paint is dry and he expects people to TRUST HIM....just ask the rats that thiis PIED PIPER flutes over the cliff...that's all you really need to know about this boiler room scurvied CANCER.

<< Previous

Bullboard Posts

Next >>

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions